Company Encyclopedia
View More
name
PASHUN INT'L
00574.HK
Pa Shun International Holdings Limited, an investment holding company, engages in the pharmaceutical distribution and manufacturing businesses in the People’s Republic of China. The company sells pharmaceutical products to wholesalers, hospitals, and other medical institutions in rural areas. It also sells pharmaceutical products manufactured by the company. The company was formerly known as Pa Shun Pharmaceutical International Holdings Limited and changed its name to Pa Shun International Holdings Limited in June 2017.
178.24 B
00574.HKMarket value -Rank by Market Cap -/-

Financial Score

09/12/2025 Update
D
Health Care DistributorsIndustry
Industry Ranking20/21
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE52.92%A
    • Profit Margin-69.19%E
    • Gross Margin12.76%D
  • Growth ScoreE
    • Revenue YoY-9.31%D
    • Net Profit YoY-280.05%E
    • Total Assets YoY-22.91%E
    • Net Assets YoY-95.10%E
  • Cash ScoreD
    • Cash Flow Margin-144.52%D
    • OCF YoY-9.31%D
  • Operating ScoreC
    • Turnover0.46C
  • Debt ScoreE
    • Gearing Ratio191.67%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Hong Kong stock movement: PASHUN INT'L plummets 22.54%

    PASHUN INT'L fell 22.54%; Sinopharm Holdings rose 0.27%, with a transaction volume of HKD 47.13 million; Shanghai Pharmaceuticals rose 0.49%, with a transaction volume of HKD 45.88 million; Yaoshi Bang fell 1.80%, with a transaction volume of HKD 36.61 million; Baiyunshan fell 0.11%, with a market value of HKD 30.2 billion

    HK Stock Movers Tracker·
    HK
    00574
    -8.16%
    HK Stock Movers Tracker·
    HK
    00574
    -8.16%

    Hong Kong Stock Movement: PASHUN INT'L down 16.90%

    PASHUN INT'L fell 16.90%; Shanghai Pharmaceuticals rose 0.49%, with a transaction volume of HKD 45.47 million; China National Pharmaceutical Group rose 0.11%, with a transaction volume of HKD 44.41 million; YaoShibang fell 1.80%, with a transaction volume of HKD 36.39 million; Baiyunshan fell 0.16%, with a market value of HKD 30.2 billion

    HK Stock Movers Tracker·
    HK
    00574
    -8.16%
    HK Stock Movers Tracker·
    HK
    00574
    -8.16%

    PASHUN INT'L released its interim results, with a loss attributable to shareholders of 9.055 million yuan, turning from profit to loss year-on-year

    PASHUN INT'L released its interim results for the period ending June 30, 2025, reporting revenue of 48.693 million yuan, a year-on-year decrease of 0.28%. The loss attributable to shareholders was 9.055 million yuan, compared to a profit of 35.427 million yuan in the same period last year, with a basic loss per share of 0.61 yuan. The loss was mainly due to the inability to replicate the one-time gain from debt restructuring of 47.4 million yuan in the same period last year

    Zhitong·
    HK
    00574
    -8.16%
    Zhitong·
    HK
    00574
    -8.16%

    "Profit Warning" PASHUN INT'L lacks one-time income, forecasts interim results in the red

    PASHUN INT'L issued a profit warning, expecting a loss of no more than 10 million RMB for the six months ending in June, compared to a profit of 35 million RMB in the same period last year. The loss is mainly due to the recognition of a one-time gain from debt restructuring of approximately 47.4 million RMB in the same period last year

    AASTOCKS·
    HK
    00574
    -8.16%
    AASTOCKS·
    HK
    00574
    -8.16%

    PASHUN INT'L issues a profit warning, expecting a mid-term net loss not exceeding 10 million yuan, a year-on-year loss from profit

    PASHUN INT'L issued a profit warning, expecting a mid-term net loss of no more than 10 million yuan for the period ending June 30, 2025, compared to a net profit of 35 million yuan for the same period in 2024. The main reason for the loss is that a one-time gain from debt restructuring of approximately 47.4 million yuan was recognized in the first half of 2024, while there is no such gain in the first half of 2025

    Zhitong·
    HK
    00574
    -8.16%
    Zhitong·
    HK
    00574
    -8.16%
    © 2025 Longbridge｜Disclaimer